Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that the Company ...

Is testosterone the next miracle drug? That seemed to be the consensus of an expert panel convened by the US Food and Drug ...

High cholesterol can lead to the buildup of fatty deposits within arteries throughout the body, causing complications like ...

CLR Labs is now compliant with EU Regulation No. 765/2008, which provides mutual recognition for assessments made by labs and ...

The government recently loosened medical marijuana rules. Experts separate fact from fiction about the drug’s safety and ...

While spending is up and consumer sentiment is down, there is another undercurrent behind the numbers.

Scientists and tourists alike have been amazed by the massive sea lion hanging out on a San Francisco pier. The species can ...

PORTSMOUTH, Va. (WAVY) – In a video for the Virginia Chapter of Man Up To Cancer called “Gathering of Wolves”, you hear this: ...

At a tense cabinet meeting where several members lobbied on behalf of the shah, he asked: "What are you guys going to advise ...

Patients with multiple myeloma (MM) have a distinct pattern of second primary malignancy (SPM), with a markedly inc ...

Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has highlighted encouraging early clinical data and fresh funding in its March 2026 ...

Karen Fancher, PharmD, BCOP, associate professor of pharmacy practice at Duquesne University and clinical oncology specialist ...